Our goal is to use basic science to improve outcomes for patients with autoimmune diseases and cancer.

To do this, we study the balance of immune activation and immune tolerance using mouse models and transitional techniques. 

We are in close proximity to the hospitals and clinics of UCLA Health, ranked #1 in California, and have ongoing clinical trials related to our work.